feeding device News
-
DSM tenders Danisco shareholding
Royal DSM, the global Life Sciences and Materials Sciences company, announces that it has tendered its 4.95% stake in Danisco to DuPont. Upon completion of the DuPont offer of DKK 700 per ordinary Danisco share, DSM expects cash proceeds of € 222 million and to report a book profit of € 140 million before tax as an exceptional item. DSM - Bright Science. Brighter Living.(TM) Royal ...
By DSM
-
Joint statement by DSM and Nutreco regarding Provimi
Royal DSM and Nutreco note recent media speculation regarding a possible acquisition of Provimi. DSM and Nutreco confirm that for this purpose they have decided to jointly explore the possibility to acquire Provimi, should this opportunity arise. A further statement will only be made if and when appropriate. DSM - Bright Science. Brighter Living.(TM) Royal DSM N.V. is a global science-based ...
By DSM
-
DSM renews €500 million credit facility
Royal DSM, the global Life Sciences and Materials Sciences company, today announces that it has entered into a committed credit facility of €500 million with certain credit relationship banks. This facility replaces a previous facility of the same amount which was scheduled to expire in October 2012. The unsecured credit facility of €500 million is for a minumum term of 5 years ...
By DSM
-
DSM appoints new Executive Vice President Corporate Strategy & Acquisitions
Royal DSM, the global Life Sciences and Materials Sciences company, today announces the following: Philip Eykerman, (1968), currently Partner at McKinsey & Company, Brussels office, will join DSM as Executive Vice President Corporate Strategy & Acquisitions, reporting to Feike Sijbesma, CEO and Chairman of the Managing Board of DSM. Philip will succeed Hein Schreuder, currently ...
By DSM
-
DSM completes acquisition of Vitatene S.A.U.
Royal DSM, the global Life Sciences and Materials Sciences company, announces today that it has completed the acquisition of Vitatene S.A.U., based in León (Spain), a producer of natural carotenoids. The acquisition was announced on 10 May 2011. The acquisition of Vitatene allows DSM to strengthen the natural carotenoids offerings of its nutrition business as consumer demand for natural ...
By DSM
-
DSM completes sale of DSM Elastomers to LANXESS
Royal DSM, the global Life Sciences and Materials Sciences company, today announces that it has completed the sale of DSM Elastomers to LANXESS for € 310 million on a cash and debt-free basis. This completes the final stage of the transformation of DSM that began with the divestment program DSM announced in September 2007 as part of its Accelerated Vision 2010 program. After all ...
By DSM
-
DSM completes acquisition of majority share in China-based UHMWPE fiber manufacturer
Royal DSM N.V. (DSM), the global Life Sciences and Materials Sciences company, today announced that it has successfully completed the acquisition of a majority share of 91.75% in Shandong ICD High Performance Fiber Co. Ltd. (ICD), based in Laiwu, Shandong province, China, as announced on 17 February 2011. Financial terms of the acquisition are not disclosed. ICD is a manufacturer of UHMWPE ...
By DSM
-
DSM announces management changes
Royal DSM, the global Life Sciences and Materials Sciences company, today announces the following: Jos Op Heij, currently Vice President Corporate Treasury, will take on the role of Senior Vice President Corporate Control and Accounting as of 1 August 2012, succeeding Loek Radix. Jos joined DSM in 1985 and holds a chartered controller degree. After positions in ICT, project management, demand ...
By DSM
-
DSM - proposed appointment to the Managing Board of Directors
The Supervisory Board of Royal DSM is pleased to announce that it will propose to the Annual General Meeting of Shareholders on 28 April 2011 to appoint Mr. Stefan Doboczky to the Managing Board of DSM with responsibility for DSM's Pharma cluster as well as the regional responsibility of DSM's activities in Asia, with effect from 1 May 2011. Mr. Doboczky will operate from two office locations, in ...
-
DSM appoints new Chief Technology Officer
Royal DSM, the global Life Sciences and Materials Sciences company, today announces the following: Marcel Wubbolts, currently Vice President R&D DSM Innovation Center, will assume the position of Chief Technology Officer for DSM as of October 1, reporting to Rob van Leen, Chief Innovation Officer. Marcel holds a PhD from the University of Groningen, NL, was post-doc and Assistent ...
By DSM
-
DSM to acquire Vitatene S.A.U. to expand position in natural carotenoids
Royal DSM, the global Life Sciences and Materials Sciences company, announces today that it has signed an agreement with P&R Group (Italy) to acquire Vitatene S.A.U., based in León (Spain), a producer of natural carotenoids. The acquisition of Vitatene allows DSM to strengthen the natural carotenoids offerings of its nutrition business as consumer demand for natural products continues ...
By DSM
-
DSM updates market on strategy progress at Capital Markets Days
Royal DSM, the global Life Sciences and Materials Sciences company, today and tomorrow will update the financial community at its annual Capital Markets Days on the progress made with its DSM in Motion: driving focused growth strategy. The company also confirms its 2011 outlook. Feike Sijbesma, CEO and Chairman of the DSM Managing Board, commented: "Against a backdrop of increased ...
By DSM
-
`It was a life saver`: New London developed device for feeding tube insertions is a world first
Researchers in London, Ont., are the first in the world to use a new device for feeding tube insertion that can improve patient safety and reduce the cost of health-care services. A team from Lawson Health Research Institute has partnered with CoapTech LLC, a medical device company, to study the use of the PUMA-G System. In October of last year, the medical and research teams were the first in ...
By CoapTech
-
DSM to contribute to new 2020 global nutrition target
/www.w3.org/1999/xhtml">DSM to contribute to new 2020 global nutrition target Royal DSM, the global Life Sciences and Materials Sciences company, today announced that it plans to help provide effective nutrition interventions to 50 million beneficiaries (pregnant and lactating woman and children under two) per year by 2020. This commitment is part of DSM's endorsement of the Global Nutrition ...
By DSM
-
CoapTech Awarded $1.6 Million from NIH for Pediatric Feeding Tube Placement Device
CoapTech Inc. announced today that the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) within the National Institutes of Health (NIH) awarded CoapTech a two-year, $1.6M R44 Small Business Innovation Research (SBIR) Phase II grant on September 22, 2020 to finalize development of and trial its Pediatric PUMA-G System. This new grant builds on a prior $225,000 Phase I SBIR ...
By CoapTech
-
Royal DSM, World Vision announce partnership to nourish millions of the world´s most vulnerable children
/www.w3.org/1999/xhtml">Royal DSM, World Vision announce partnership to nourish millions of the world's most vulnerable children Working together to achieve lasting progress in global health and development by improving the nutritional status of mothers and children Flagship programme in Tanzania to fortify maize flour with essential micronutrients 22 May 2013 - Royal ...
By DSM
-
Backed by $18 Million and a Nationwide Agreement With One of the Largest Private Hospital Networks in The U.S., ENvizion® Unveils Enteral Feeding Tube ‘GPS’ Tech
ENvizion®, the FDA 510(k) cleared leader in enteral feeding placement navigation technology, announces its agreement with one of the largest private hospital networks in the U.S., with more than one hundred hospitals, to provide ENvizion’s feeding tube placement navigation devices nationwide. The company’s endeavor is backed by $18 million in investment. Key investors include ...
-
DSM Successfully Completes Tender Offer for Martek and Expects to Complete Acquisition Today
Royal DSM N.V. (NYSE Euronext: DSM KON), the global Life Sciences and Materials Sciences company, announced today that it has successfully completed the subsequent offering period to its all-cash tender offer to purchase all of the outstanding shares of common stock of Martek Biosciences Corporation at a price of $31.50 per share. The previously announced subsequent offering period expired at ...
-
Green Industrial Revolution Needed to Feed and Fuel the Future
"The so-called fossil-age will make a shift to the bio-based-economy. In two or three centuries from now, people will look back on our civilization as a merely brief moment in history where we in a period of just about 250 years shifted our total economy to coal, oil and gas. To make the shift back to living with, and especially off, nature, we need to start this shift now. We are at a turning ...
By DSM
-
DSM and Rostekhnologii to cooperate on biotechnology and functional materials
/www.w3.org/1999/xhtml">DSM and Rostekhnologii to cooperate on biotechnology and functional materials Royal DSM, the global Life Sciences and Materials Sciences company, announces today that it has signed a Memorandum of Understanding (MOU) for a strategic partnership with Rostekhnologii (Rostec), a Russian State Corporation, in the fields of biotechnology and functional materials. The MOU ...
By DSM
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you